Literature DB >> 19948833

Conditional deletion of neuronal cyclin-dependent kinase 5 in developing forebrain results in microglial activation and neurodegeneration.

Satoru Takahashi1, Toshio Ohshima, Motoyuki Hirasawa, Tej K Pareek, Thomas H Bugge, Alexei Morozov, Kenji Fujieda, Roscoe O Brady, Ashok B Kulkarni.   

Abstract

Neuronal migration disorders are often identified in patients with epilepsy refractory to medical treatment. The prolonged or repeated seizures are known to cause neuronal death; however, the mechanism underlying seizure-induced neuronal death remains to be elucidated. An essential role of cyclin-dependent kinase 5 (Cdk5) in brain development has been demonstrated in Cdk5(-/-) mice, which show neuronal migration defects and perinatal lethality. Here, we show the consequences of Cdk5 deficiency in the postnatal brain by generating Cdk5 conditional knockout mice, in which Cdk5is selectively eliminated from neurons in the developing forebrain. The conditional mutant mice were viable, but exhibited complex neurological deficits including seizures, tremors, and growth retardation. The forebrain not only showed disruption of layering, but also neurodegenerative changes accompanied by neuronal loss and microglial activation. The neurodegenerative changes progressed with age and were accompanied by up-regulation of the neuronal tissue-type plasminogen activator, a serine protease known to mediate microglial activation. Thus age-dependent neurodegeneration in the Cdk5 conditional knockout mouse brain invoked a massive inflammatory reaction. These findings indicate an important role of Cdk5 in inflammation, and also provide a mouse model to examine the possible involvement of inflammation in the pathogenesis of progressive cognitive decline in patients with neuronal migration disorders.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19948833      PMCID: PMC2797893          DOI: 10.2353/ajpath.2010.081158

Source DB:  PubMed          Journal:  Am J Pathol        ISSN: 0002-9440            Impact factor:   4.307


  40 in total

Review 1.  Role of microglia in inflammation-mediated neurodegenerative diseases: mechanisms and strategies for therapeutic intervention.

Authors:  Bin Liu; Jau-Shyong Hong
Journal:  J Pharmacol Exp Ther       Date:  2003-01       Impact factor: 4.030

2.  Serial analysis of gene expression in a microglial cell line.

Authors:  H Inoue; M Sawada; A Ryo; H Tanahashi; T Wakatsuki; A Hada; N Kondoh; K Nakagaki; K Takahashi; A Suzumura; M Yamamoto; T Tabira
Journal:  Glia       Date:  1999-12       Impact factor: 7.452

Review 3.  Cdk5 on the brain.

Authors:  D S Smith; P L Greer; L H Tsai
Journal:  Cell Growth Differ       Date:  2001-06

4.  Cyclin-dependent kinase 5 prevents neuronal apoptosis by negative regulation of c-Jun N-terminal kinase 3.

Authors:  Bing-Sheng Li; Lei Zhang; Satoru Takahashi; Wu Ma; Howard Jaffe; Ashok B Kulkarni; Harish C Pant
Journal:  EMBO J       Date:  2002-02-01       Impact factor: 11.598

5.  Cyclin-dependent kinase 5/p35 contributes synergistically with Reelin/Dab1 to the positioning of facial branchiomotor and inferior olive neurons in the developing mouse hindbrain.

Authors:  Toshio Ohshima; Masaharu Ogawa; Kyoko Takeuchi; Satoru Takahashi; Ashok B Kulkarni; Katsuhiko Mikoshiba
Journal:  J Neurosci       Date:  2002-05-15       Impact factor: 6.167

6.  Cell type-specific roles for tissue plasminogen activator released by neurons or microglia after excitotoxic injury.

Authors:  Chia-Jen Siao; Susana R Fernandez; Stella E Tsirka
Journal:  J Neurosci       Date:  2003-04-15       Impact factor: 6.167

7.  Tissue plasminogen activator mediates microglial activation via its finger domain through annexin II.

Authors:  Chia-Jen Siao; Stella E Tsirka
Journal:  J Neurosci       Date:  2002-05-01       Impact factor: 6.167

8.  Tau phosphorylation by cyclin-dependent kinase 5/p39 during brain development reduces its affinity for microtubules.

Authors:  Satoru Takahashi; Taro Saito; Shin-ichi Hisanaga; Harish C Pant; Ashok B Kulkarni
Journal:  J Biol Chem       Date:  2003-01-20       Impact factor: 5.157

9.  Inhibition of plasminogen activation protects against ganglion cell loss in a mouse model of retinal damage.

Authors:  Xu Zhang; Aisha Chaudhry; Shravan K Chintala
Journal:  Mol Vis       Date:  2003-06-12       Impact factor: 2.367

10.  The neuronal expression of MYC causes a neurodegenerative phenotype in a novel transgenic mouse.

Authors:  Hyoung-gon Lee; Gemma Casadesus; Akihiko Nunomura; Xiongwei Zhu; Rudy J Castellani; Sandy L Richardson; George Perry; Dean W Felsher; Robert B Petersen; Mark A Smith
Journal:  Am J Pathol       Date:  2009-01-22       Impact factor: 4.307

View more
  20 in total

1.  Cdk5 regulates developmental remodeling of mushroom body neurons in Drosophila.

Authors:  Svetlana Smith-Trunova; Ranjini Prithviraj; Joshua Spurrier; Irina Kuzina; Qun Gu; Edward Giniger
Journal:  Dev Dyn       Date:  2015-10-14       Impact factor: 3.780

Review 2.  Cell cycle regulation during neurogenesis in the embryonic and adult brain.

Authors:  Arquimedes Cheffer; Attila Tárnok; Henning Ulrich
Journal:  Stem Cell Rev Rep       Date:  2013-12       Impact factor: 5.739

3.  Cyclin-dependent kinase 5 activity is required for allogeneic T-cell responses after hematopoietic cell transplantation in mice.

Authors:  David Askew; Tej K Pareek; Saada Eid; Sudipto Ganguly; Megan Tyler; Alex Y Huang; John J Letterio; Kenneth R Cooke
Journal:  Blood       Date:  2016-11-14       Impact factor: 22.113

4.  Phosphorylation of glutamyl-prolyl tRNA synthetase by cyclin-dependent kinase 5 dictates transcript-selective translational control.

Authors:  Abul Arif; Jie Jia; Robyn A Moodt; Paul E DiCorleto; Paul L Fox
Journal:  Proc Natl Acad Sci U S A       Date:  2011-01-10       Impact factor: 11.205

5.  Cyclin-dependent kinase 5 regulates E2F transcription factor through phosphorylation of Rb protein in neurons.

Authors:  Akira Futatsugi; Elias Utreras; Parvathi Rudrabhatla; Howard Jaffe; Harish C Pant; Ashok B Kulkarni
Journal:  Cell Cycle       Date:  2012-04-15       Impact factor: 4.534

6.  Bi-allelic TMEM94 Truncating Variants Are Associated with Neurodevelopmental Delay, Congenital Heart Defects, and Distinct Facial Dysmorphism.

Authors:  Joshi Stephen; Sateesh Maddirevula; Sheela Nampoothiri; John D Burke; Matthew Herzog; Anju Shukla; Katharina Steindl; Ascia Eskin; Siddaramappa J Patil; Pascal Joset; Hane Lee; Lisa J Garrett; Tadafumi Yokoyama; Nicholas Balanda; Steven P Bodine; Nathanial J Tolman; Patricia M Zerfas; Allison Zheng; Georgia Ramantani; Katta M Girisha; Cecilia Rivas; Pujar V Suresh; Abdel Elkahloun; Hessa S Alsaif; Salma M Wakil; Laila Mahmoud; Rehab Ali; Michaela Prochazkova; Ashok B Kulkarni; Tawfeg Ben-Omran; Dilek Colak; H Douglas Morris; Anita Rauch; Julian A Martinez-Agosto; Stanley F Nelson; Fowzan S Alkuraya; William A Gahl; May Christine V Malicdan
Journal:  Am J Hum Genet       Date:  2018-12-06       Impact factor: 11.025

7.  Hypomyelination phenotype caused by impaired differentiation of oligodendrocytes in Emx1-cre mediated Cdk5 conditional knockout mice.

Authors:  Xiaojuan He; Satoru Takahashi; Hiromi Suzuki; Tsutomu Hashikawa; Ashok B Kulkarni; Katsuhiko Mikoshiba; Toshio Ohshima
Journal:  Neurochem Res       Date:  2011-01-06       Impact factor: 3.996

8.  p39 Is Responsible for Increasing Cdk5 Activity during Postnatal Neuron Differentiation and Governs Neuronal Network Formation and Epileptic Responses.

Authors:  Wenqi Li; Megan E Allen; Yanfang Rui; Li Ku; Guanglu Liu; Andrew N Bankston; James Q Zheng; Yue Feng
Journal:  J Neurosci       Date:  2016-11-02       Impact factor: 6.167

9.  A truncated peptide from p35, a Cdk5 activator, prevents Alzheimer's disease phenotypes in model mice.

Authors:  Varsha Shukla; Ya-Li Zheng; Santosh K Mishra; Niranjana D Amin; Joseph Steiner; Philip Grant; Sashi Kesavapany; Harish C Pant
Journal:  FASEB J       Date:  2012-10-04       Impact factor: 5.191

Review 10.  The Role of Cdk5 in Alzheimer's Disease.

Authors:  Shu-Lei Liu; Chong Wang; Teng Jiang; Lan Tan; Ang Xing; Jin-Tai Yu
Journal:  Mol Neurobiol       Date:  2015-07-31       Impact factor: 5.590

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.